Week In Review: SinoMab To IPO On Hong Kong Exchange

Novartis expects to submit 50 new drug applications in China between 2019 and 2023 – ten … reported its filing for a Hong Kong IPO has been accepted by the Exchange. Founded in 2001 by Dr …
( read original story …)